Sign in
4

Changes in Ownership

PLIANT THERAPEUTICS, INC. Filed Acc 0001746473-26-000020

Options or other derivatives

  • Chief Financial Officer acquired 400,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Cummings Keith Lamont Chief Financial Officer 2026-01-22 Grant or award · Stock Option (Right to Buy) +400,000 400,000 D
Loading xslF345X05/wk-form4_1769463411.xml…